Yongning Xin

2.8k total citations
89 papers, 1.9k citations indexed

About

Yongning Xin is a scholar working on Epidemiology, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yongning Xin has authored 89 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Epidemiology, 33 papers in Hepatology and 22 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yongning Xin's work include Liver Disease Diagnosis and Treatment (68 papers), Lipid metabolism and disorders (22 papers) and Diet, Metabolism, and Disease (16 papers). Yongning Xin is often cited by papers focused on Liver Disease Diagnosis and Treatment (68 papers), Lipid metabolism and disorders (22 papers) and Diet, Metabolism, and Disease (16 papers). Yongning Xin collaborates with scholars based in China and United States. Yongning Xin's co-authors include Shousheng Liu, Shiying Xuan, Quanjiang Dong, Lizhen Chen, Mengzhen Dong, Shui-Xian Du, Likun Zhuang, Jie Zhang, Xuefeng Ma and Zhonghua Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Microbiology.

In The Last Decade

Yongning Xin

85 papers receiving 1.8k citations

Peers

Yongning Xin
Yueyong Zhu China
William Alazawi United Kingdom
John Lubel Australia
Münevver Demir Germany
Όλγα Γιουλεμέ Greece
Kenneth I. Zheng China
Jeong‐Ju Yoo South Korea
Edmondo Falleti Italy
Narendra S. Choudhary India
Yong‐Ping Chen China
Yueyong Zhu China
Yongning Xin
Citations per year, relative to Yongning Xin Yongning Xin (= 1×) peers Yueyong Zhu

Countries citing papers authored by Yongning Xin

Since Specialization
Citations

This map shows the geographic impact of Yongning Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongning Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongning Xin more than expected).

Fields of papers citing papers by Yongning Xin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongning Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongning Xin. The network helps show where Yongning Xin may publish in the future.

Co-authorship network of co-authors of Yongning Xin

This figure shows the co-authorship network connecting the top 25 collaborators of Yongning Xin. A scholar is included among the top collaborators of Yongning Xin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongning Xin. Yongning Xin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Han, et al.. (2024). MiR-146a-5p-enriched exosomes inhibit M1 macrophage activation and inflammatory response by targeting CD80. Molecular Biology Reports. 51(1). 1133–1133. 6 indexed citations
2.
3.
4.
Ding, Xiaoqian, et al.. (2023). Chronic Infection Considerations in Nonalcoholic Fatty Liver Disease Patients. Gene Expression. 22(3). 192–202. 1 indexed citations
5.
Zhang, Haiying, et al.. (2022). Association between the LRP5 rs556442 gene polymorphism and the risks of NAFLD and CHD in a Chinese Han population. BMC Gastroenterology. 22(1). 305–305. 2 indexed citations
6.
Wang, Yifen, et al.. (2022). MiR-146a-5p, targeting ErbB4, promotes 3T3-L1 preadipocyte differentiation through the ERK1/2/PPAR-γ signaling pathway. Lipids in Health and Disease. 21(1). 54–54. 12 indexed citations
7.
8.
Shi, Tingting, et al.. (2020). Can elevated concentrations of ALT and AST predict the risk of ‘recurrence’ of COVID-19?. Epidemiology and Infection. 148. e218–e218. 13 indexed citations
9.
Chen, Lizhen, et al.. (2019). Association between TM6SF2 rs58542926 polymorphism and non-alcoholic fatty liver disease in Qingdao Han Population and molecular mechanism. SHILAP Revista de lepidopterología. 44(2). 127–131. 1 indexed citations
10.
Liu, Shousheng, et al.. (2018). Apolipoprotein A5 gene polymorphisms are associated with non-alcoholic fatty liver disease. Hepatobiliary & pancreatic diseases international. 17(3). 214–219. 7 indexed citations
11.
12.
Zhang, Yang, Linlin Lu, David W. Victor, Yongning Xin, & Shiying Xuan. (2016). Ursodeoxycholic Acid and S-adenosylmethionine for the Treatment of Intrahepatic Cholestasis of Pregnancy: A Meta-analysis. Hepatitis Monthly. 16(8). e38558–e38558. 30 indexed citations
13.
Chen, Lizhen, Harry Hua‐Xiang Xia, Yongning Xin, Zhonghua Lin, & Shiying Xuan. (2015). TM6SF2 E167K Variant, a Novel Genetic Susceptibility Variant, Contributing to Nonalcoholic Fatty Liver Disease. Journal of Clinical and Translational Hepatology. 3(4). 265–270. 29 indexed citations
14.
Huang, Haiyan, Yongning Xin, Man Jiang, et al.. (2015). [Role of SREBP-1c in risk of liver disease associated with the triacylglycerol lipase PNPLA3 I148M variant].. PubMed. 23(10). 771–4. 1 indexed citations
15.
Wang, Lili, Jianhua Zhou, Yongning Xin, et al.. (2015). Bacterial overgrowth and diversification of microbiota in gastric cancer. European Journal of Gastroenterology & Hepatology. 28(3). 261–266. 170 indexed citations
16.
Xu, Xin, et al.. (2015). Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis. Lipids in Health and Disease. 14(1). 158–158. 47 indexed citations
17.
Zhang, Haiying, et al.. (2014). Apolipoprotein C3 Gene Polymorphisms Are Not a Risk Factor for Developing Non-Alcoholic Fatty Liver Disease: A Meta-Analysis. Hepatitis Monthly. 14(10). e23100–e23100. 18 indexed citations
18.
Xu, Jing, Yongning Xin, Weihong Lu, et al.. (2013). [Polymorphism rs738409 in PNPLA3 is associated with inherited susceptibility to non-alcoholic fatty liver disease].. PubMed. 21(8). 619–23. 6 indexed citations
19.
Zheng, Ming‐Hua, Li‐Xin Qiu, Yongning Xin, et al.. (2009). Tumor necrosis factor-α-308A allele may have a protective effect for chronic hepatitis B virus infection in Mongoloid populations. International Journal of Infectious Diseases. 14(7). e580–e585. 20 indexed citations
20.
Xuan, Shiying, Yongning Xin, Quanjiang Dong, et al.. (2008). Association between the presence of H pylori in the liver and hepatocellular carcinoma: A meta-analysis. World Journal of Gastroenterology. 14(2). 307–307. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yueyong Zhu Breakdown of academic impact, for papers by William Alazawi Breakdown of academic impact, for papers by John Lubel Breakdown of academic impact, for papers by Münevver Demir Breakdown of academic impact, for papers by Όλγα Γιουλεμέ Breakdown of academic impact, for papers by Kenneth I. Zheng Breakdown of academic impact, for papers by Jeong‐Ju Yoo Breakdown of academic impact, for papers by Edmondo Falleti Breakdown of academic impact, for papers by Narendra S. Choudhary Breakdown of academic impact, for papers by Yong‐Ping Chen
Rankless by CCL
2026